Back

Association of baseline disability and major adverse outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding Cardiovascular Risk Assessment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Marco Proietti

University of Milan, Milan (Italy)

12 More presentations in this session

Presentation thumbnail
Doctor I. Hammami (Oxford, GB)
Abstract
Presentation thumbnail
Doctor A. Conti (Massa, IT)
Abstract Slides
Presentation thumbnail
Doctor A. Baluja (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Doctor A. Katbeh (Damascus, SY)
Abstract Slides
Presentation thumbnail
Professor D. Linz (Maastricht, NL)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of progressively impaired renal function on major adverse outcomes in european patients with atrial fibrillation: a report from the ESC EORP-AF long-term general registry
2 September 2019
thumbnail
Congress Presentation
Impact of long-term endurance sport on the association between atrial fibrillation and mortality. a prospective cohort study
25 April 2024
thumbnail
Congress Presentation
Structured rehabilitation for patients with atrial fibrillation based on an integrated care approach
29 August 2025
thumbnail
Congress Presentation
Bleeding risks with frailty and multimorbidity in patients with atrial fibrillation. A nationwide analysis of 1.4 million subjects
31 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources